To overcome this limitation, we created an Il17ra−/− in the FVB/n background using Crispr/Cas technology,22 and then the InsGAS transgene was introgressed into the Il17ra-/- mice to investigate the contribution of the IL-17RA to the development of GC in a murine model. The gene discussed is IL17RA; the disease is gastric cancer.